IL6 and obesity due to melanocortin 4 receptor deficiency: Compared with the use of metformin, Qu (300 mg/kg), can assist metformin in reducing the levels of serum IL-6 and TNF-α, relieving the inflammatory response of obesity, and has good safety, with no obvious organ toxicity (89).